US Stock MarketDetailed Quotes
CTSO Cytosorbents
- 0.900
- +0.020+2.28%
Close May 31 16:00 ET
48.88MMarket Cap-1525P/E (TTM)
0.910High0.860Low53.51KVolume0.885Open0.880Pre Close47.51KTurnover0.12%Turnover RatioLossP/E (Static)54.31MShares4.29052wk High2.58P/B41.30MFloat Cap0.78252wk Low--Dividend TTM45.88MShs Float98.750Historical High--Div YieldTTM5.68%Amplitude0.750Historical Low0.887Avg Price1Lot Size
Cytosorbents Key Stats
EPS
According to the latest financial report of Cytosorbents, the latest earnings per share (TTM) for the company is -0.12. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Cytosorbents's free cash flow? The latest report shows it as -4.96M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Cytosorbents shows that the company's current ratio is 1.49, indicating healthy liquidity.
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Cytosorbents, the quick ratio is 1.15, indicating that the company can meet its short-term debt obligations.
Quarterly
Loading...
ROE
Want to learn more about the financial health of Cytosorbents? The latest ROE figure is -30.13%, indicating that the company has stable profitability.
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Cytosorbents, the total asset return on investment (ROA) is -12.67%.
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Cytosorbents's latest financial report to see how their gross margin is doing - currently at 64.23%.
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Cytosorbents, the net profit margin is -64.97%, which is a good sign for its profitability.
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg